Jennifer L Waller
Overview
Explore the profile of Jennifer L Waller including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
177
Citations
3796
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Caylor N, Walsh D, Xie D, Waller J, Wilkins T
J Gen Intern Med
. 2025 Feb;
PMID: 40000521
No abstract available.
2.
Smaha K, Talebi N, Waller J, Baer S, Bollag W
Am J Med Sci
. 2025 Feb;
PMID: 39952290
Background: In end-stage renal disease (ESRD), reduced renal function affects medication response and clearance, increasing risk of adverse drug reactions. Renal disease is a risk factor for poor prognosis in...
3.
Patel Y, Waller J, El Hajj J, Bollag W, Baer S, Elam J, et al.
Kidney360
. 2025 Jan;
PMID: 39814407
Background: Glucocorticoids are central to vasculitis treatment but increase vertebral fracture risk. This study assessed whether vasculitis as the cause of ESRD is associated with incident vertebral fracture, controlling for...
4.
Robinson R, Taylor A, Cato A, Patel V, Waller J, Wayne N
J Pharm Pract
. 2024 Sep;
:8971900241285248.
PMID: 39303087
Patients maintained on extracorporeal membrane oxygenation (ECMO) often require systemic anticoagulation to prevent circuit clotting and systemic thromboembolic complications. The optimal intensity of anticoagulation to balance the risk of bleeding...
5.
Kim K, Smaha K, Waller J, Bollag W, Baer S, Taskar V, et al.
Am J Med Sci
. 2024 Aug;
369(1):88-95.
PMID: 39209259
Background: Insomnia, a known cardiovascular risk factor, is common in end-stage renal disease (ESRD) patients. There is growing acknowledgment of a potential bidirectional relationship between cardiovascular diseases and sleep disorders....
6.
Wynter Z, Gorham J, Thompson A, Mundy C, Waller J, Stansfield B
J Perinatol
. 2024 May;
44(11):1591-1596.
PMID: 38724605
Objective: Double-blind randomized control trial of early addition of a bovine milk-derived human milk fortifier (HMF) in very low birth weight (VLBW) infants (NCT05228535). Methods: VLBW infants were randomized to...
7.
Shah P, Hanson M, Waller J, Tran S, Baer S, Taskar V, et al.
Pathogens
. 2024 Jan;
13(1).
PMID: 38276167
Vitiligo is an autoimmune condition that causes patchy skin depigmentation. Although the mechanism by which vitiligo induces immunocompromise is unclear, other related autoimmune diseases are known to predispose those affected...
8.
Duchesne G, Xia D, Waller J, Bollag W, Mohammed A, Padala S, et al.
J Investig Med
. 2024 Jan;
72(3):287-293.
PMID: 38183213
In the general population, abdominal aortic aneurysm (AAA) is synonymous with vascular disease and associated with increased mortality. Vascular disease is common in end-stage renal disease (ESRD) patients on dialysis,...
9.
Momin R, Baer S, Waller J, Young L, Tran S, Taskar V, et al.
Medicina (Kaunas)
. 2023 Dec;
59(12).
PMID: 38138248
: Atopic dermatitis (AD), also known as eczema, is a common chronic inflammatory skin condition affecting 16.5 million adults in the United States. AD is characterized by an impaired epidermal...
10.
Acree L, Day T, Groves M, Waller J, Bollag W, Tran S, et al.
J Investig Med
. 2023 Dec;
72(2):220-232.
PMID: 38102746
Deep neck space infections (DNSI) are severe infections within the layers of neck fascia that are known to be associated with underlying immunocompromised states. Although uremia associated with kidney disease...